Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0U8PR
|
|||
| Former ID |
DNCL001741
|
|||
| Drug Name |
HPP-593
|
|||
| Indication | Diabetic complication [ICD-11: 5A2Y] | Phase 1 | [1] | |
| Dyslipidemia [ICD-11: 5C80-5C81] | Phase 1 | [1] | ||
| Company |
High Point Pharmaceuticals
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01524406) Safety Study of HPP593 in Subjects During and After Limb Immobilization. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.